GB0604783D0 - Use of substituted oxime compounds for the treatment of food related disorders - Google Patents

Use of substituted oxime compounds for the treatment of food related disorders

Info

Publication number
GB0604783D0
GB0604783D0 GBGB0604783.1A GB0604783A GB0604783D0 GB 0604783 D0 GB0604783 D0 GB 0604783D0 GB 0604783 A GB0604783 A GB 0604783A GB 0604783 D0 GB0604783 D0 GB 0604783D0
Authority
GB
United Kingdom
Prior art keywords
treatment
related disorders
oxime compounds
food related
substituted oxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0604783.1A
Other versions
GB2435830A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0604783A priority Critical patent/GB2435830A/en
Publication of GB0604783D0 publication Critical patent/GB0604783D0/en
Publication of GB2435830A publication Critical patent/GB2435830A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0604783A 2006-03-09 2006-03-09 Oxime ether compounds for the treatment of conditions associated with food uptake Withdrawn GB2435830A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0604783A GB2435830A (en) 2006-03-09 2006-03-09 Oxime ether compounds for the treatment of conditions associated with food uptake

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0604783A GB2435830A (en) 2006-03-09 2006-03-09 Oxime ether compounds for the treatment of conditions associated with food uptake

Publications (2)

Publication Number Publication Date
GB0604783D0 true GB0604783D0 (en) 2006-04-19
GB2435830A GB2435830A (en) 2007-09-12

Family

ID=36241307

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0604783A Withdrawn GB2435830A (en) 2006-03-09 2006-03-09 Oxime ether compounds for the treatment of conditions associated with food uptake

Country Status (1)

Country Link
GB (1) GB2435830A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848549B (en) * 2019-04-29 2022-04-22 苏州大学 Aryl oxime compound and preparation and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432506A1 (en) * 1978-08-02 1980-02-29 Esteve Internal Sa Prod NOVEL 6-METHOXY-2-ACETYLNAPHTHALENE OXIME DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2449081A1 (en) * 1979-02-13 1980-09-12 Esteve Internacional S Prod NOVEL P-CHLOROACETOPHENONE OXIME DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
US4246277A (en) * 1979-06-22 1981-01-20 Albert Rolland S.A. Lowering the concentration of plasma triglycerides
BRPI0408325A (en) * 2003-03-13 2006-03-21 Ono Pharmaceutical Co imino ether-derived compounds and medicines containing the compounds as the active ingredient
EP1732566A4 (en) * 2004-04-05 2010-01-13 Takeda Pharmaceutical 6-azaindole compound
US20080081825A1 (en) * 2004-04-28 2008-04-03 Hisao Nakai Nitrogen-Containing Heterocyclic Compounds and Medicinal Use Thereof

Also Published As

Publication number Publication date
GB2435830A (en) 2007-09-12

Similar Documents

Publication Publication Date Title
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
IL190920A0 (en) Compounds for the treatment of metabolic disorders
ZA200808178B (en) Imidazolothiazole compounds for the treatment of disease
HK1152939A1 (en) Carboxamide compounds for the treatment of metabolic disorders
ZA200805645B (en) Compounds for the treatment of metabolic disorders
ZA200806455B (en) Use of 2-imidazoles for the treatment of CNS disorders
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
GB0604780D0 (en) Use of substituted piperazine compounds for the treatment of food related disorders
IL192877A0 (en) Use of 2-imidazoles for the treatment of cns disorders
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
GB0604781D0 (en) Use of substituted phenyl-piperazine compounds for the treatment of food related disorders
PL1982178T3 (en) Methods for the treatment of affective disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
GB0604783D0 (en) Use of substituted oxime compounds for the treatment of food related disorders
HK1129112A1 (en) 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders
IL192982A0 (en) Compounds for the treatment of metabolic disorders
GB0604778D0 (en) Use of substituted amine compouds fo the treatment of food related disorders
GB0604775D0 (en) Use Of Substituted Benzimidazole Sulfonamide Compounds For The Treatment Of Food Related Disorders

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)